Judgement bias in medical device recall decisions

March 4, 2017

(HealthDay)—The characteristics of the signal in user feedback of adverse events associated with medical devices and the situated context of decision makers correlate with judgement bias in reacting to these adverse events, according to research published online Jan. 29 in Production and Operations Management.

Ujjal Kumar Mukherjee, Ph.D., from the University of Illinois at Urbana-Champaign, and Kingshuk K. Sinha, from the University of Minnesota in Minneapolis, developed an integrative theoretical framework for identifying the sources of judgment bias in product recall decisions in response to reports of . User-generated reports (big and unstructured data) on adverse events related to medical devices were analyzed using a combination of econometric and predictive analytic methods.

The researchers found that noisy signals in user feedback (i.e., high noise-to-signal ratio) correlated with the likelihood of under-reaction; user feedback related to high severity adverse events correlated with a likelihood of high over-reaction. Conditions related to the situated context of managers that correlate with the likelihood of under- and over-reaction were also identified.

"The findings of this study are consequential for firms and government regulatory agencies in that they shed light on the sources of judgment bias in recall decisions, thereby ensuring that such decisions are made correctly and in a timely manner," the authors write. "Our findings also contribute towards improving the post-launch market surveillance of products (e.g., ) by making it more evidence-based and predictive."

Explore further: Many spinal manipulation trials don't report adverse events

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Many spinal manipulation trials don't report adverse events

September 27, 2016
(HealthDay)—Many randomized clinical trials (RCTs) involving spinal manipulative therapy (SMT) do not report adverse events, although there has been an increase in such reporting since publication of the 2010 Consolidated ...

Melanoma therapy tied to cutaneous adverse events

March 16, 2016
(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...

Obesity ups risks in pediatric procedural sedation

June 12, 2015
(HealthDay)—For pediatric patients undergoing procedural sedation, obesity is associated with increased risk of adverse respiratory events and frequency of airway interventions, according to research published in the July ...

Preemies have lasting risk for anesthesia adverse events

February 26, 2016
(HealthDay)—Preterm children have an increased risk of developing sedation/anesthesia adverse events, which continues up to age 23 years, according to a study published online Feb. 25 in Pediatrics.

Daily INR measurement best for hospitalized patients on warfarin

December 23, 2015
(HealthDay)—For hospitalized patients, international normalized ratio (INR) monitoring less frequently than daily is associated with increased odds of warfarin-associated adverse events, according to a study published online ...

Harms reporting in trials of orlistat

August 16, 2016
The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.